Working collaboratively to provide creative solutions to protein challenges in drug discovery
Advancing Biopharmaceutical Solutions
This month, we showcase two case studies demonstrating our expertise in biopharmaceutical development - from optimising production processes to characterising critical quality attributes.
Optimising Biopharmaceutical Production
This case study explores development of a robust production process, optimising construct design and downstream processing suitable for large-scale manufacture.
Learn how mass spectrometry was applied to elucidate critical quality attributes of a biotherapeutic protein, providing key insights into its structure, consistency, and overall integrity for drug development. Read more.
Early Validation of HTS Hits with X-ray Crystallography
Explore how X-ray crystallography enhances early validation of high-throughput screening hits, providing detailed structural insights to accelerate drug discovery. Read more.
Rick Davies on Joining Sygnature
After two months as Director of Sygnature Protein Science and Structural Biology, Rick Davies shares insights on the transition, collaboration, and future opportunities.
